UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO.) Filed by the Registrant / / Filed by a Party other than the Registrant /X/ Check the appropriate box: / / Preliminary Proxy Statement / / Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) / / Definitive Proxy Statement /X/ Definitive Additional Materials / / Soliciting Material Under Rule 14a-12 RURAL/METRO CORPORATION - -------------------------------------------------------------------------------- (Name of Registrant as Specified in Its Charter) ACCIPITER LIFE SCIENCES FUND, LP ACCIPITER LIFE SCIENCES FUND II, LP ACCIPITER LIFE SCIENCES FUND (OFFSHORE), LTD. ACCIPITER LIFE SCIENCES FUND II (OFFSHORE), LTD. ACCIPITER LIFE SCIENCES FUND II (QP), LP CANDENS CAPITAL, LLC ACCIPITER CAPITAL MANAGEMENT, LLC GABE HOFFMAN NICOLE VIGLUCCI MOHSIN Y. MEGHJI - -------------------------------------------------------------------------------- (Name of Persons(s) Filing Proxy Statement, if Other Than the Registrant) -1-Payment of Filing Fee (Check the appropriate box): /X/ No fee required. / / Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: - -------------------------------------------------------------------------------- (2) Aggregate number of securities to which transaction applies: - -------------------------------------------------------------------------------- (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): - -------------------------------------------------------------------------------- (4) Proposed maximum aggregate value of transaction: - -------------------------------------------------------------------------------- (5) Total fee paid: - -------------------------------------------------------------------------------- / / Fee paid previously with preliminary materials: - -------------------------------------------------------------------------------- / / Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing. (1) Amount previously paid: - -------------------------------------------------------------------------------- (2) Form, Schedule or Registration Statement No.: - -------------------------------------------------------------------------------- -2- (3) Filing Party: - -------------------------------------------------------------------------------- (4) Date Filed: Accipiter Life Sciences Fund, LP ("ALS Fund"), together with the other participants named herein, is filing materials contained in this Schedule 14A with the Securities and Exchange Commission ("SEC") in connection with the solicitation of proxies for the election of a slate of director nominees at the 2007 annual meeting of stockholders (the "Annual Meeting") of Rural/Metro Corporation, a Delaware corporation (the "Company"). ALS Fund has not yet filed a proxy statement with the SEC with regard to the Annual Meeting Item 1: On September 11, 2007, Accipiter Capital Management, LLC issued the following press release: NEWS RELEASE FOR IMMEDIATE RELEASE ACCIPITER CAPITAL MANAGEMENT EXPRESSES CONCERN OVER RURAL/METRO'S FAILURE TO RELEASE FOURTH QUARTER AND FISCAL YEAR END FINANCIAL RESULTS NEW YORK, NEW YORK, SEPTEMBER 11, 2007 - Accipiter Capital Management expressed its concern today over Rural/Metro Corporation's (Nasdaq: RURL) lack of communication with stockholders regarding the Company's fourth quarter and fiscal year end financial results. Gabe Hoffman, Managing Member of Accipiter Capital Management, stated "Accipter, a long-term, major stockholder owning nearly 15% of the outstanding shares of Rural, is concerned with the Company's lack of communication with stockholders regarding its release of fourth quarter and fiscal year end financial numbers. At the end of July, Rural issued a press release trumpeting the success of its short-term internal initiatives and indicating its intent to hold a management-hosted conference call to discuss Rural's fourth quarter and fiscal year end results. However, it is now less than two days from the SEC filing deadline, and stockholders have been treated to nothing but silence, not even call-in details for management's conference call. We demand that Rural promptly inform stockholders of its plans to report fourth quarter and fiscal year end results, as well as inform stockholders of any potential plans to file for an extension on its 10-K filing" # # # Contacts Dan Burch / Dan Sullivan MacKenzie Partners, Inc. 212-929-5940 / 1-800-322-2885 -3- CERTAIN INFORMATION CONCERNING PARTICIPANTS Accipiter Life Sciences Fund, LP ("ALS Fund"), together with the other Participants (as defined below), intend to make a preliminary filing with the Securities and Exchange Commission ("SEC") of a proxy statement and accompanying proxy card to be used to solicit votes for the election of a slate of director nominees at the 2007 annual meeting of stockholders of Rural/Metro Corporation, a Delaware corporation (the "Company"). ALS FUND ADVISES ALL STOCKHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT WHEN IT IS AVAILABLE BECAUSE IT WILL CONTAIN IMPORTANT INFORMATION. SUCH PROXY STATEMENT WILL BE AVAILABLE AT NO CHARGE ON THE SEC'S WEB SITE AT HTTP://WWW.SEC.GOV. IN ADDITION, THE PARTICIPANTS IN THE SOLICITATION WILL PROVIDE COPIES OF THE PROXY STATEMENT WITHOUT CHARGE UPON REQUEST. REQUESTS FOR COPIES SHOULD BE DIRECTED TO THE PARTICIPANTS' PROXY SOLICITOR, MACKENZIE PARTNERS, INC. BY TELEPHONE AT 800-322-2885 OR EMAIL AT PROXY@MACKENZIEPARTNERS.COM. The participants in the proxy solicitation are anticipated to be Accipiter Life Sciences Fund (Offshore), Ltd., ("ALS Fund Offshore"), Accipiter Life Sciences Fund II, LP, ("ALS Fund II"), Accipiter Life Sciences Fund II (Offshore), Ltd., ("ALS Fund II Offshore"), Accipiter Life Sciences Fund II (QP), LP, ("ALS Fund II QP") (together with ALS Fund, ALS Fund Offshore, ALS Fund II, ALS Fund II Offshore, ALS Fund II QP, the "Accipiter Entities"), Accipiter Capital Management, LLC, ("Accipiter Management"), Candens Capital, LLC, ("Candens Capital"), Gabe Hoffman, Nicole Viglucci and Mohsin Y. Meghji. As of the date of this filing, ALS Fund, ALS Fund II and ALS Fund II QP beneficially owned 745,595, 534,951 and 611,901 shares of Common Stock of the Company, respectively. As the general partner of each of ALS Fund, ALS Fund II and ALS Fund II QP, Candens Capital may be deemed to beneficially own the 1,892,447 shares of Common Stock of the Company collectively owned by ALS Fund, ALS Fund II and ALS Fund II QP. As of the date of this filing, ALS Fund Offshore and ALS Fund II Offshore beneficially owned 749,867 and 1,059,333 shares of Common Stock of the Company, respectively. As the investment manager of each of ALS Fund Offshore and ALS Fund II Offshore, Accipiter Management may be deemed to beneficially own the 1,809,200 shares of Common Stock of the Company collectively owned by ALS Fund Offshore and ALS Fund II Offshore. As of the date of this filing Mr. Hoffman may be deemed to beneficially own 3,701,647 shares of Common Stock collectively owned by the Accipiter Entities. Mr. Hoffman has sole voting and dispositive power with respect to the 3,701,647 Shares owned by the Accipiter Entities. Each of Candens Capital, Accipiter Management and Gabe Hoffman disclaims beneficial ownership of the shares of Common Stock of the Company owned by the Accipiter Entities except to the extent of its or his pecuniary interest therein. Currently, neither Nicole Viglucci nor Mohsin Y. Meghji beneficially owns any shares of Common Stock of the Company. -4-
- Company Dashboard
- Filings
- Holdings
-
DFAN14A Filing
Accipiter Capital Management DFAN14AAdditional proxy materials by non-management
Filed: 11 Sep 07, 12:00am